Aquestive Therapeutics (AQST) Interest Expenses (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Interest Expenses of $7.4 million for Q1 2026, down 14.82% year-over-year from $8.7 million in Q1 2025, and up 387.66% quarter-over-quarter from $1.5 million in Q4 2025.
Aquestive Therapeutics (AQST) Interest Expenses (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Interest Expenses history runs 10 years deep, the most recent figure standing at $7.4 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 14.82% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (down 14.82% YoY), while the FY2025 annual figure was $113.2 million, up 19.69% from the prior year.
- Interest Expenses for Q1 2026 stood at $7.4 million, up from $1.5 million in the prior quarter.
- The five-year high for Interest Expenses was $11.0 million in Q1 2023, with the low at $538000.0 in Q4 2023.
- The 5-year median for Interest Expenses is $5.6 million (2024), against an average of $6.0 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses jumped 932.71% in 2024, then slumped 72.57% in 2025.
- Aquestive Therapeutics' Interest Expenses stood at $1.5 million in 2022, then tumbled by 64.93% to $538000.0 in 2023, then surged by 932.71% to $5.6 million in 2024, then plunged by 72.57% to $1.5 million in 2025, then soared by 387.66% to $7.4 million in 2026.
- Business Quant data shows AQST's Interest Expenses at $7.4 million in Q1 2026, $1.5 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aquestive Therapeutics | 558.10 Mn | 558.10 Mn | 9.80 Mn | 2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.24 Mn |
| Jun 30, 2026 | 16.24 Mn |
| Mar 31, 2026 | 7.43 Mn |
| Mar 31, 2026 | 7.43 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Sep 30, 2024 | 9.36 Mn |
| Sep 30, 2024 | 9.36 Mn |
| Jun 30, 2024 | 9.67 Mn |
| Jun 30, 2024 | 9.67 Mn |
| Mar 31, 2024 | 9.81 Mn |
| Mar 31, 2024 | 9.81 Mn |